GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly hal
Centred on its main themes of sustainability, inclusivity, and digital health, Day One of the Future of Health summit kicks off post-welcome with a panel: ‘Partnering to build resilient and sust
A trade organisation representing pharma manufacturers in Europe has said plans to restrict the use of fluorinated substances known as PFAS could make manufacturing “grind
While patient centricity remains vital to the life sciences industry, as companies come under pressure to reduce their carbon footprint, we are increasingly seeing different aspects of the
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.